New Illuma Growing-up Infant Formula Now Available throughout China

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

WyethNutritionFormula

More Like This

PR Newswire associated0

Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant Formula in China

PR Newswire associated0

Illuma, Global Pioneer in HMO Research, Launches Traceability Journey in Switzerland, Unveiling Next-Generation HMO Innovations

PR Newswire associated0

Wyeth launches China's first infant formula with two types of HMOs, leading the way in HMO innovation

PR Newswire associated0

dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

PR Newswire associated0

Yili Launches Pro-Kido Infant Formula in Hong Kong Amid Global Expansion Efforts

PR Newswire associated0

Yili Secures Four World Dairy Innovation Awards at the 18th Global Dairy Congress

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found in breast milk, significantly improving the intestinal environment of healthy full-term infants. (Graphic: Business Wire)

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

Access to Nutrition Initiative study reveals that Food for infants and toddlers from leading brands fails to meet marketing and nutritional standards